Other
Short-term debt and current portion of long-term debt
Eli Lilly Short-term debt and current portion of long-term debt increased by 144.6% to $4.00B in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryLeverage
SignalLower is better
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
A significant increase may signal higher refinancing risk or a shift in capital structure, while a decrease indicates debt reduction or successful long-term refinancing.
Detailed definition
This represents the portion of total debt obligations, including bank loans, commercial paper, and the current portion o...
Peer comparison
Standard debt metric; peers report this as current portion of long-term debt or short-term borrowings.
Metric ID:
other_debt_currentHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $1.64B | $4.00B |
| QoQ Change | — | +144.6% |
Range$1.64B – $4.00B
Short-term debt and current portion of long-term debt at Other Companies
Frequently Asked Questions
- What is Eli Lilly's short-term debt and current portion of long-term debt?
- Eli Lilly (LLY) reported short-term debt and current portion of long-term debt of $4.00B in Q1 2026.
- What does short-term debt and current portion of long-term debt mean?
- The amount of debt the company must repay within the next year.